The 2019 TCT Conference: Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR
Atara's collaborating investigators will present an oral encore presentation of the interim results for tab-cel® (tabelecleucel) from a multicenter expanded access protocol (EAP) study for patients with EBV associated cancers. These results were previously presented at the 60th American Society of Hematology (ASH) Annual Meeting on December 3, 2018. The 2019 TCT Conference will be held February 20-24, 2019, at the Hilton Americas Houston in Houston, TX. Details for the presentation are as follows:
Abstract Title: Efficacy of Donor and ‘Third Party’ (Tabelecleucel) EBV-Specific T Cells for Treatment of Central Nervous System (CNS) EBV-PTLD
Lead Author: Susan E. Prockop, M.D.
Session Title: S-OA-M Oral Abstract - Session M - Infection and Immunity